Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 71
Filtrar
1.
Appl Opt ; 57(31): 9414-9422, 2018 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-30461987

RESUMO

A novel experimental setup for two-photon induced polarization spectroscopy of xenon using a single dye laser is demonstrated. The experimental setup for probing this two-photon xenon transition using this technique has been developed in the High Enthalpy Flow Diagnostics Group of the Institute of Space Systems. The characterization of the setup is achieved through a polarization lineshape modelling approach accounting for absorption, dispersion, and imperfections in the alignment of the analyzing polarizer for asymmetrical polarization profiles. It is demonstrated that the lineshape modelling approach yields consistent results for measurements with pronounced asymmetrical lineshape properties as well as for those with symmetrical lineshapes. For the first time, data on pressure broadening and pressure dependent redshift of the absorption center wavelength of xenon 7p[1/2]0 is presented. The results show a pressure broadening of 1.475 pm/bar full width at half maximum and a redshift of 0.8425 pm/bar.

2.
Br J Cancer ; 109(9): 2347-55, 2013 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-24104963

RESUMO

BACKGROUND: Genomic rearrangements at the fragile site FRA1E may disrupt the dihydropyrimidine dehydrogenase gene (DPYD) which is involved in 5-fluorouracil (5-FU) catabolism. In triple-negative breast cancer (TNBC), a subtype of breast cancer frequently deficient in DNA repair, we have investigated the susceptibility to acquire copy number variations (CNVs) in DPYD and evaluated their impact on standard adjuvant treatment. METHODS: DPYD CNVs were analysed in 106 TNBC tumour specimens using multiplex ligation-dependent probe amplification (MLPA) analysis. Dihydropyrimidine dehydrogenase (DPD) expression was determined by immunohistochemistry in 146 tumour tissues. RESULTS: In TNBC, we detected 43 (41%) tumour specimens with genomic deletions and/or duplications within DPYD which were associated with higher histological grade (P=0.006) and with rearrangements in the DNA repair gene BRCA1 (P=0.007). Immunohistochemical analysis revealed low, moderate and high DPD expression in 64%, 29% and 7% of all TNBCs, and in 40%, 53% and 7% of TNBCs with DPYD CNVs, respectively. Irrespective of DPD protein levels, the presence of CNVs was significantly related to longer time to progression in patients who had received 5-FU- and/or anthracycline-based polychemotherapy (hazard ratio=0.26 (95% CI: 0.07-0.91), log-rank P=0.023; adjusted for tumour stage: P=0.037). CONCLUSION: Genomic rearrangements in DPYD, rather than aberrant DPD protein levels, reflect a distinct tumour profile associated with prolonged time to progression upon first-line chemotherapy in TNBC.


Assuntos
Variações do Número de Cópias de DNA , Di-Hidrouracila Desidrogenase (NADP)/genética , Recidiva Local de Neoplasia/genética , Neoplasias de Mama Triplo Negativas/genética , Antimetabólitos Antineoplásicos/uso terapêutico , Proteína BRCA1/genética , Sítios Frágeis do Cromossomo/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Feminino , Fluoruracila/uso terapêutico , Deleção de Genes , Duplicação Gênica/efeitos dos fármacos , Duplicação Gênica/genética , Rearranjo Gênico/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/enzimologia , Recidiva Local de Neoplasia/patologia , Prognóstico , Radiografia , Neoplasias de Mama Triplo Negativas/diagnóstico por imagem , Neoplasias de Mama Triplo Negativas/tratamento farmacológico , Neoplasias de Mama Triplo Negativas/enzimologia
3.
Clin Genet ; 82(5): 478-83, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21919902

RESUMO

In families with clustering of breast and ovarian cancer, molecular testing of the major susceptibility genes BRCA1/2 helps to identify patients with disease mutations and healthy persons at high risk who can participate in targeted intervention programs. We investigated 5559 families from the German Consortium for Hereditary Breast and Ovarian Cancer included between 1997 and 2008 and treated under clinical routine conditions. In each family an index patient/person had been screened for deleterious mutations in BRCA1/2. Healthy relatives agreed to predictive testing in 888 of 1520 BRCA1/2 mutation-positive families (58%). Of 2646 eligible unaffected first-degree relatives 1143 decided to be tested (43%). In 325 families with BRCA1/2-positive index patients one related BC/OC patient was tested and 39 (12.0%; 95% confidence interval: 8.7-16.0%) discrepant cases found. A second related individual was screened in 163 of 3388 (4.9%) families with BRCA1/2-negative index patient and in eight families a BRCA1/2 mutation was found. In BRCA1/2 mutation-positive families, BC/OC patients lacking the familial mutation have to be expected at a rather high rate. In families with BRCA1/2-negative index patient we recommend a second screening if another patient with a high probability of carrying a BRCA1/2 mutation is available.


Assuntos
Proteína BRCA2/genética , Testes Genéticos , Ubiquitina-Proteína Ligases/genética , Adulto , Idoso , Neoplasias da Mama/genética , Feminino , Predisposição Genética para Doença , Alemanha , Humanos , Pessoa de Meia-Idade , Mutação , Neoplasias Ovarianas/genética , Linhagem , Fenótipo , Fatores de Risco
4.
Br J Cancer ; 105(12): 1934-9, 2011 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-22033276

RESUMO

BACKGROUND: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of this study was to evaluate the association between inherited variation in this oncogene and risk of breast cancer. METHODS: A single-nucleotide polymorphism from the PIK3CA locus that was associated with breast cancer in a study of Caucasian breast cancer cases and controls from the Mayo Clinic (MCBCS) was genotyped in 5436 cases and 5280 controls from the Cancer Genetic Markers of Susceptibility (CGEMS) study and in 30 949 cases and 29 788 controls from the Breast Cancer Association Consortium (BCAC). RESULTS: Rs1607237 was significantly associated with a decreased risk of breast cancer in MCBCS, CGEMS and all studies of white Europeans combined (odds ratio (OR)=0.97, 95% confidence interval (CI) 0.95-0.99, P=4.6 × 10(-3)), but did not reach significance in the BCAC replication study alone (OR=0.98, 95% CI 0.96-1.01, P=0.139). CONCLUSION: Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer.


Assuntos
Neoplasias da Mama/enzimologia , Predisposição Genética para Doença , Variação Genética , Fosfatidilinositol 3-Quinases/genética , Neoplasias da Mama/genética , Estudos de Casos e Controles , Classe I de Fosfatidilinositol 3-Quinases , Feminino , Humanos
5.
Klin Padiatr ; 221(5): 302-4, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19707993

RESUMO

We report on a 4 month old male infant with respiratory syncytial virus (RSV) infection leading to acute respiratory distress syndrome (ARDS). A diagnostic algorithm including extended infectiological and immunological work-up revealed absence of CD40-ligand. ARDS was treated successfully with a complex respiratory therapy plus intravenous immunoglobulin substitution. Molecular analysis detected mutations in the CD40L gene (Hyper-IgM syndrome Type 1). The case underlines the importance of an extended diagnostic work-up in an uncommonly severe course of respiratory infection in early infancy.


Assuntos
Ligante de CD40/deficiência , Ligante de CD40/genética , Infecções por Citomegalovirus/diagnóstico , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/diagnóstico , Infecções Oportunistas/diagnóstico , Síndrome do Desconforto Respiratório/diagnóstico , Infecções por Vírus Respiratório Sincicial/diagnóstico , Algoritmos , Cuidados Críticos/métodos , Infecções por Citomegalovirus/genética , Infecções por Citomegalovirus/terapia , Análise Mutacional de DNA , Diagnóstico Diferencial , Éxons , Humanos , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/genética , Síndrome de Imunodeficiência com Hiper-IgM Tipo 1/terapia , Lactente , Masculino , Infecções Oportunistas/genética , Infecções Oportunistas/terapia , Infecções por Vírus Respiratório Sincicial/genética , Infecções por Vírus Respiratório Sincicial/terapia
6.
Br J Cancer ; 99(6): 974-7, 2008 Sep 16.
Artigo em Inglês | MEDLINE | ID: mdl-18781154

RESUMO

The close functional relationship between p53 and the breast cancer susceptibility genes BRCA1 and BRCA2 has promoted the investigation of various polymorphisms in the p53 gene as possible risk modifiers in BRCA1/2 mutation carriers. Specifically, two polymorphisms in p53, c.97-147ins16bp and p.Arg72Pro have been analysed as putative breast cancer susceptibility variants, and it has been recently reported that a p53 haplotype combining the absence of the 16-bp insertion and the presence of proline at codon 72 (No Ins-72Pro) was associated with an earlier age at the onset of the first primary tumour in BRCA2 mutation carriers in the Spanish population. In this study, we have evaluated this association in a series of 2932 BRCA1/2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2.


Assuntos
Proteína BRCA1/genética , Proteína BRCA2/genética , Neoplasias da Mama/genética , Mutação em Linhagem Germinativa/genética , Polimorfismo Genético/genética , Proteína Supressora de Tumor p53/genética , Adulto , Neoplasias da Mama/patologia , Feminino , Predisposição Genética para Doença , Genótipo , Haplótipos , Heterozigoto , Humanos , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/patologia , Fatores de Risco
7.
Rheumatology (Oxford) ; 46(1): 154-60, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16782988

RESUMO

OBJECTIVE: To define non-bacterial osteitis (NBO) as a clinical entity possibly associated with autoimmune manifestations. Patients with sterile osteitis were analysed to develop diagnostic criteria. METHODS: A total of 89 patients with non-bacterial inflammatory bone lesions were observed for a median of 49 months. History, diagnostic imaging, laboratory and histological data were obtained. Mutation analysis in the genes PSTPIP1 and PSTPIP2 was performed. RESULTS: Patients had an onset of disease at a median age of 10 yrs [interquartile range (IQR) 7.5-12] and suffered a median period of 21 (IQR 9-52) months with a median of three foci per patient. Twenty percent of all the patients demonstrated associated autoimmune disorders, particularly of the skin and bowel. The majority of bone lesions were located in the vertebrae and metaphyses. Slight-to-moderate elevation of inflammation values were found in all the patients and antinuclear antibodies were elevated in 30%. Non-steroidal anti-inflammatory drugs (NSAIDs) were effective in 85% of the patients. HLA-B27 and Human Leukocyte Antigen-DR (HLA-DR)-classification did not differ from the general population. Autoimmune diseases in 40% of all the families, multiply affected family members, linkage to 18q21 and mouse models strongly indicate a genetic basis for NBO. We observed three different courses of disease regarding the duration of complaints, rate of complications and associated autoimmune manifestations leading to a new classification of NBO. CONCLUSIONS: Clinical analysis of our cohort leads us to define NBO as a distinct disease entity with three clinical presentations: acute NBO, chronic recurrent multifocal osteomyelitis or persistent chronic NBO. Diagnostic criteria were proposed to differentiate NBO from diseases with similar clinical presentation.


Assuntos
Doenças Autoimunes/diagnóstico , Osteíte/diagnóstico , Proteínas Adaptadoras de Transdução de Sinal/genética , Adolescente , Adulto , Anti-Inflamatórios não Esteroides/uso terapêutico , Doenças Autoimunes/genética , Doenças Autoimunes/imunologia , Criança , Pré-Escolar , Doença Crônica , Proteínas do Citoesqueleto/genética , Diagnóstico Diferencial , Feminino , Fraturas Espontâneas/etiologia , Humanos , Mediadores da Inflamação/sangue , Masculino , Pessoa de Meia-Idade , Mutação , Osteíte/complicações , Osteíte/genética , Osteíte/imunologia , Prognóstico , Recidiva , Estudos Retrospectivos , Fraturas da Coluna Vertebral/etiologia
8.
J Med Genet ; 43(6): e30, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16740914

RESUMO

BACKGROUND: Golabi, Ito, and Hall reported a family with X linked mental retardation (XLMR), microcephaly, postnatal growth deficiency, and other anomalies, including atrial septal defect, in 1984. METHODS: This family was restudied as part of our ongoing study of XLMR, but significant linkage to X chromosome markers could not be found. Extreme short stature and microcephaly as well as other new clinical findings were observed. Mutations in the polyglutamine tract binding protein 1 gene (PQBP1) have recently been reported in four XLMR disorders (Renpenning, Hamel cerebro-palato-cardiac, Sutherland-Haan, and Porteous syndromes) as well as in several other families. The clinical similarity of our family to these patients with mutations in PQBP1, particularly the presence of microcephaly, short stature, and atrial septal defect, prompted examination of this gene. RESULTS: A missense mutation in PQBP1 was identified which changed the conserved tyrosine residue in the WW domain at position 65 to a cysteine (p.Y65C). CONCLUSIONS: This is the first missense mutation identified in PQBP1 and the first mutation in the WW domain of the gene. The WW domain has been shown to play an important role in the regulation of transcription by interacting with the PPxY motif found in transcription factors. The p.Y65C mutation may affect the proper functioning of the PQBP1 protein as a transcriptional co-activator.


Assuntos
Proteínas de Transporte/genética , Deficiência Intelectual Ligada ao Cromossomo X/genética , Mutação de Sentido Incorreto , Proteínas Nucleares/genética , Adolescente , Adulto , Sequência de Aminoácidos , Proteínas de Transporte/química , Sequência Conservada , Análise Mutacional de DNA , Proteínas de Ligação a DNA , Comunicação Interatrial/diagnóstico , Comunicação Interatrial/genética , Humanos , Masculino , Deficiência Intelectual Ligada ao Cromossomo X/diagnóstico , Deficiência Intelectual Ligada ao Cromossomo X/mortalidade , Microcefalia/diagnóstico , Microcefalia/genética , Dados de Sequência Molecular , Proteínas Nucleares/química , Linhagem , Estrutura Terciária de Proteína , Alinhamento de Sequência , Síndrome
9.
Breast Cancer Res ; 7(5): R775-9, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16168123

RESUMO

INTRODUCTION: Unclassified variants (UVs) of unknown clinical significance are frequently detected in the BRCA2 gene. In this study, we have investigated the potential pathogenic relevance of the recurrent UV S384F (BRCA2, exon 10). METHODS: For co-segregation, four women from a large kindred (BN326) suffering from breast cancer were analysed. Moreover, paraffin-embedded tumours from two patients were analysed for loss of heterozygosity. Co-occurrence of the variant with a deleterious mutation was further determined in a large data set of 43,029 index cases. Nature and position of the UV and conservation among species were evaluated. RESULTS: We identified the unclassified variant S384F in three of the four breast cancer patients (the three were diagnosed at 41, 43 and 57 years of age). One woman with bilateral breast cancer (diagnosed at ages 32 and 50) did not carry the variant. Both tumours were heterozygous for the S384F variant, so loss of the wild-type allele could be excluded. Ser384 is not located in a region of functional importance and cross-species sequence comparison revealed incomplete conservation in the human, dog, rodent and chicken BRCA2 homologues. Overall, the variant was detected in 116 patients, five of which co-occurred with different deleterious mutations. The combined likelihood ratio of co-occurrence, co-segregation and loss of heterozygosity revealed a value of 1.4 x 10-8 in favour of neutrality of the variant. CONCLUSION: Our data provide conclusive evidence that the S384F variant is not a disease causing mutation.


Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Variação Genética , Mutação em Linhagem Germinativa , Perda de Heterozigosidade , Polimorfismo de Nucleotídeo Único , Adulto , Substituição de Aminoácidos , Segregação de Cromossomos , DNA de Neoplasias/genética , Feminino , Lateralidade Funcional , Humanos , Pessoa de Meia-Idade
10.
J Clin Immunol ; 24(5): 515-22, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15359110

RESUMO

Hypogammaglobulinemia is a common symptom in different immunodeficiencies. It is, however, not usually associated with Epstein-Barr virus (EBV) infections. The X-linked lymphoproliferative disease (XLP) on the other hand shows immunological changes in response to the EBV. Here we report three previously healthy boys, all of which developed persistent hypogammaglobulinemia following severe acute infectious mononucleosis. All three patients revealed T-cell abnormalities including inverted CD4/CD8 and increased CD8(+) T-cell numbers. The number of IFN-gamma-producing T cells were markedly increased in the two patients studied so far. In addition, patient 2 showed mainly T cells, instead of B cells, to be infected with the EBV. Apart from an uncle of patient 3, who died of malignant lymphoma, family history was unremarkable in all cases. All three patients exhibited mutations in the SH2D1A gene, establishing the diagnosis of XLP. Protein expression was found on immunoblot analysis in one patient with a missense mutation. Development of persistent hypogammaglobulinemia after severe primary EBV infection seems to be a specific diagnostic sign for XLP even in males with unremarkable family history.


Assuntos
Agamaglobulinemia/imunologia , Doenças Genéticas Ligadas ao Cromossomo X/imunologia , Mononucleose Infecciosa/imunologia , Transtornos Linfoproliferativos/imunologia , Southern Blotting , Criança , Pré-Escolar , Análise Mutacional de DNA , Humanos , Lactente , Peptídeos e Proteínas de Sinalização Intracelular/genética , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Transtornos Linfoproliferativos/genética , Masculino , Proteína Associada à Molécula de Sinalização da Ativação Linfocitária
11.
J Med Genet ; 41(9): 679-83, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15342698

RESUMO

Mental retardation is the most frequent cause of serious handicap in children and young adults. The underlying causes of this heterogeneous condition are both acquired and genetically based. A recently performed refinement of the linkage interval in a large Belgian family with mild to severe non-syndromic X linked mental retardation, classified as MRX9, revealed a candidate region of 11.3 Mb between markers DXS228 and DXS1204 on the short arm of the X chromosome. In order to identify the underlying disease gene in the MRX9 family, we established a gene catalogue for the candidate region and performed comprehensive mutation analysis by direct sequencing. A human homologue of the bacterial 23S rRNA methyltransferase Fstj, the FTSJ1 gene, is located within this region and displayed a sequence alteration in the conserved acceptor splice site of intron 3 (IVS3-2A>G) in all tested patients and carrier females of this family. In contrast, it was absent in all unaffected male family members tested. The mutation results in skipping of exon 4 and introduces a premature stop codon in exon 5, probably leading to a severely truncated protein. Our finding indicates that a protein, possibly associated with ribosomal stability, can be linked to X linked mental retardation (XLMR).


Assuntos
Cromossomos Humanos X/genética , Deficiência Intelectual/genética , Metiltransferases/genética , Mutação/genética , Proteínas Nucleares/genética , Sítios de Splice de RNA/genética , Sequência de Aminoácidos , Bélgica , Feminino , Humanos , Masculino , Metiltransferases/química , Dados de Sequência Molecular , Proteínas Nucleares/química , Linhagem , RNA Mensageiro/análise , RNA Mensageiro/genética
12.
J Med Genet ; 40(6): 418-23, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12807962

RESUMO

X linked progressive cone-rod dystrophy (COD) is a retinal disease primarily affecting the cone photoreceptors. The disease is genetically heterogeneous and two loci, COD1 (Xp21.1-11.4) and COD2 (Xq27.2-28), have been previously identified. COD1 was recently shown to be caused by mutations in RPGR exon ORF15 (Xp21.1), the gene that is also responsible for RP3 type retinitis pigmentosa. In this study, we performed a linkage study to map the disease gene in a large Finnish family with X linked cone-rod dystrophy, using a panel of 39 X chromosomal markers. Several recombinations between the disease gene and markers in the Xp21.1-p11.4 region have excluded COD1 as a candidate locus in this family. Consistent with the linkage results, no mutation was detected by direct PCR sequencing of the coding region of RPGR, including exon ORF15. The COD2 locus has been also excluded as the site of the gene on the basis of negative lod score values obtained for COD2 linked markers. The disease causing gene of the studied COD family has been localised between the markers DXS10042 and DXS8060 on Xp11.4-q13.1. Positive pairwise lod scores >3 were obtained for markers DXS993, MAOB, DXS1055, and DXS1194. Since this locus is distinct from the previously identified two loci, COD1 and COD2, our results establish a new third genetic locus for X linked progressive cone-rod dystrophy and further expands our knowledge about the genetic heterogeneity underlying this disease entity.


Assuntos
Cromossomos Humanos X/genética , Retinose Pigmentar/genética , Mapeamento Cromossômico , Análise Mutacional de DNA , Feminino , Finlândia , Ordem dos Genes/genética , Ligação Genética/genética , Marcadores Genéticos , Testes Genéticos , Haplótipos/genética , Humanos , Masculino , Linhagem
13.
Zentralbl Gynakol ; 125(12): 494-506, 2003 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-14755360

RESUMO

Women with familial predisposition for breast and ovarian cancer represent a small group of patients with very high risk for developing breast and/ or ovarian cancer before the age of 50 years. The individual breast cancer risk can be assessed by genetic counselling and can be specified by genetic diagnostics. As part of the gynaecological consultation, adequate preventive measures are offered. Psycho-oncological counselling may help in decision making. For hereditary carcinomas, counselling is still not considered as a routine medical care, even though basic and routine preventive measures are insufficient for this group of high risk patients. Within the last years, 12 specialized centres in Germany have developed a patient care concept for women with a familial risk for breast and ovarian cancer. Establishment of these centres for familial breast and ovarian cancer and use of evidence-based medical care was initiated in a nationwide interdisciplinary joint research project and supported by the German Cancer AiD. These measures were integrated in a quality assurance concept for structure, process and result optimization. Thus, all requirements for introducing these services into routine patient management have been fulfilled.


Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/prevenção & controle , Aconselhamento , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/prevenção & controle , Educação de Pacientes como Assunto/normas , Aconselhamento/normas , Medicina Baseada em Evidências/normas , Feminino , Alemanha , Humanos , Garantia da Qualidade dos Cuidados de Saúde , Inquéritos e Questionários , Serviços de Saúde da Mulher/normas
14.
Gynecol Endocrinol ; 16(2): 107-11, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12012620

RESUMO

An asymptomatic woman (age 38 years) with a family history of ovarian malignancies was referred for presymptomatic genetic testing of mutations in the BRCA genes. A familial Swyer syndrome with the occurrence of dysgerminomas is the most likely diagnosis. However, in our case, all known causes of this heterogeneous disorder have been excluded pointing to the existence of another yet unknown genetic locus. The family history revealed three affected paternal aunts. Two of them developed ovarian malignancies at 13 and 15 years of age, and died at ages 19 and 20. The third aunt, 82 years old, was affected by this disease at the age of 35. She underwent hormonal treatment for 3 years starting at the age of 15 because of primary amenorrhea. Under this treatment she developed nearly complete secondary sexual characteristics. Karyotype analysis revealed a normal male karyotype (46 XY, QFQ). Pelvic ultrasound showed an uterus of normal size, incompatible with an androgen resistance syndrome or a defect in testosterone biosynthesis. We excluded a mutation in the sex-determining region on chromosome Y (SRY) by direct sequencing of the SRY gene. An involvement of the subtelomeric region of chromosome 9p (9p 24.3) recently reported to be involved in XY-sex reversal phenotypes was excluded by molecular testing for loss of heterozygosity as well as fluorescence in situ hybridization studies. Analyses of the DAX1 gene in the dosage sensitive sex reversal locus on chromosome Xp21 by Southern blot analysis showed no duplications.


Assuntos
Disgenesia Gonadal 46 XY/genética , Cariotipagem , Fenótipo , Cromossomos Sexuais , 17-alfa-Hidroxiprogesterona/sangue , Adulto , Androstenodiona/sangue , Cromossomos Humanos Par 9/genética , Cromossomos Humanos X/genética , Análise Mutacional de DNA , Di-Hidrotestosterona/sangue , Transtornos do Desenvolvimento Sexual , Estradiol/sangue , Feminino , Hormônio Foliculoestimulante/sangue , Genitália/patologia , Disgenesia Gonadal 46 XY/sangue , Disgenesia Gonadal 46 XY/patologia , Humanos , Hibridização in Situ Fluorescente , Hormônio Luteinizante/sangue , Masculino , Neoplasias Ovarianas/genética , Linhagem , Progesterona/sangue , Prolactina/sangue , Valores de Referência , Análise de Sequência de DNA , Testosterona/sangue , Ultrassonografia , Útero/diagnóstico por imagem
15.
Int J Cancer ; 97(4): 472-80, 2002 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-11802209

RESUMO

The main focus of this German-wide multi-center study was to establish a BRCA1/2 mutation profile and to determine family types with high frequencies of mutations in these genes. In a comprehensive study, the entire coding sequences of the breast cancer genes BRCA1 and BRCA2 were analyzed in 989 unrelated patients from German breast/ovarian cancer families. A total of 77 BRCA1 and 63 BRCA2 distinct deleterious mutations were found in 302 patients. More than (1/3) of these mutations are novel and might be specific for the German population. Eighteen common mutations were found in 68% of cases in BRCA1 and 13 recurrent mutations in 44% of cases in BRCA2, facilitating prescreening approaches. Haplotype analysis indicate that 14 out of 20 recurrent mutations are likely originating from a common founder. An additional 50 different rare sequence variants with unknown relevance for tumorigenesis were found in 72 families. Correlation of BRCA1/BRCA2 detection rates with family history identified families with both breast and ovarian cancer to be at highest risk for BRCA1/BRCA2 mutations (43% and 10%, respectively), followed by families with at least 2 premenopausal cases of breast cancer (24% BRCA1 and 13% BRCA2 mutations). These data provide strong evidence for further predisposing genes in the German population. In breast cancer families with 2 or 3 affected females but only a single or no premenopausal case, mutations were detected with low frequencies (about 10% or less for both genes). The decision for or against molecular diagnosis is now aided by considering the expected mutation detection rates that greatly depend on family history and structure.


Assuntos
Neoplasias da Mama/genética , Genes BRCA1 , Genes BRCA2 , Mutação , Síndromes Neoplásicas Hereditárias/genética , Adulto , Idade de Início , Alelos , Neoplasias da Mama/epidemiologia , Análise Mutacional de DNA , DNA de Neoplasias/genética , Éxons/genética , Feminino , Efeito Fundador , Mutação da Fase de Leitura , Frequência do Gene , Predisposição Genética para Doença , Testes Genéticos , Alemanha/epidemiologia , Haplótipos/genética , Humanos , Masculino , Pessoa de Meia-Idade , Mutação de Sentido Incorreto , Neoplasias Primárias Múltiplas/epidemiologia , Neoplasias Primárias Múltiplas/genética , Síndromes Neoplásicas Hereditárias/epidemiologia , Neoplasias Ovarianas/epidemiologia , Neoplasias Ovarianas/genética , Prevalência , Splicing de RNA/genética , Fatores de Risco , Deleção de Sequência
16.
Int J Food Microbiol ; 68(1-2): 105-13, 2001 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-11545209

RESUMO

In many countries Staphylococcus aureus is considered to be the second or third most common pathogen causing outbreaks of food poisoning, only outnumbered by Salmonella spp. and in competition with Clostridium perfringens. Often the consumption of ham or meat containing staphylococcal enterotoxins (SE) is identified as cause of the illness. Thus, to gain an insight into the prevalence of S. aureus and its emetic enterotoxins in raw pork and uncooked smoked ham and to investigate how the prevalence of the pathogen is influenced during the fabrication process, a total of 135 samples of raw pork, salted meat and ready-for-sale uncooked smoked ham were examined for the prevalence of S. aureus and staphylococcal enterotoxins A to D (SEA-SED). To this means classical cultural methods were employed as well as molecular biological techniques (PCR) and the results were compared. In 25.9% of all samples S. aureus was detected by culture whereas 51.1% of the samples showed a positive result when PCR was used for the detection of the pathogen. Fresh meat was contaminated most often. By PCR, 62.2% were identified as being S. aureus positive compared to 57.7% positive samples using the cultural technique. The detection rate during the fabrication process declined significantly. The pathogen was cultivated from 8.9% of the salted meat samples. Here, 55.6% of the samples reacted positively in the PCR, and finally, in approximately a third of the ready-for-sale smoked hams, S. aureus genes were found. From 11.1% of these samples, the pathogen could be isolated by culture. From these results, we conclude that the PCR used in this study is more sensitive than the classical cultural method. By PCR, one or more staphylococcal enterotoxin genes were found in 24 of the 135 examined samples. This means that 34.8% of the staphylococcal strains identified using the PCR technique were enterotoxigenic. Using the SET-RPLA, a percentage of 28.6% enterotoxigenic isolates was ascertained. No staphylococcal enterotoxin formation was detected by the SET-RPLA in ready-for-sale ham, although SE-genes were found by PCR. The detection of SE-genes by PCR is faster and easier to perform than the SET-RPLA.


Assuntos
Enterotoxinas/análise , Produtos da Carne/microbiologia , Intoxicação Alimentar Estafilocócica/epidemiologia , Staphylococcus aureus/isolamento & purificação , Animais , Contagem de Colônia Microbiana , Manipulação de Alimentos/métodos , Alemanha/epidemiologia , Reação em Cadeia da Polimerase/métodos , Polimorfismo de Fragmento de Restrição , Prevalência , Sensibilidade e Especificidade , Staphylococcus aureus/genética , Staphylococcus aureus/metabolismo , Suínos
17.
Graefes Arch Clin Exp Ophthalmol ; 239(3): 167-72, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11405065

RESUMO

BACKGROUND: Mutations in the OA1 gene on the short arm of the X chromosome are known to cause X-linked ocular albinism (x1OA) in males. A four-generation family with this disorder, including asymptomatic carrier females, was investigated by molecular analysis of the OA1 gene. METHODS: DNA samples were available from 22 individuals of this family, including 6 affected males and 6 obligate carriers. The nine exons of the OA1 gene were amplified and further analyzed by SSCP and sequencing. RESULTS: A detailed clinical examination of the index patient and two female carriers showed the typical signs of ocular albinism. Visual evoked potential responses showed markedly asymmetrical responses from the two hemispheres in the affected person as well as in the carriers, as a result of misrouting and decussation of optic nerve fibers. Molecular genetic analysis demonstrated a previously undescribed 29-bp deletion at position 225-253 in exon 1 of the OA1 gene, which segregated in the family. CONCLUSION: Clinical examination combined with molecular genetic analysis enhances the potential for a precise diagnosis for persons at risk of x1OA and provide an accurate basis for genetic counseling.


Assuntos
Albinismo Ocular/genética , Éxons/genética , Ligação Genética/genética , Deleção de Sequência , Cromossomo X/genética , Adulto , Albinismo Ocular/diagnóstico , Sequência de Aminoácidos , Sequência de Bases , Pré-Escolar , Análise Mutacional de DNA , Eletrorretinografia , Potenciais Evocados Visuais , Feminino , Fundo de Olho , Triagem de Portadores Genéticos , Humanos , Lactente , Masculino , Dados de Sequência Molecular , Oftalmoscopia , Linhagem , Polimorfismo Conformacional de Fita Simples , Acuidade Visual
18.
Dev Dyn ; 221(1): 72-80, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11357195

RESUMO

Chondromodulin-I (CHM1) was identified recently as an angiogenesis inhibitor in cartilage. It is highly expressed in the avascular zones of cartilage but is absent in the late hypertrophic region, which is invaded by blood vessels during enchondral ossification. Blast searches with the C-terminal part of CHM1 in available databases led to the identification of human and mouse cDNAs encoding a new protein, Tendin, that shares high homology with CHM1. Based on computer predictions, Tendin is a type II transmembrane protein containing a putative proteinase cleavage and two glycosylation sites. Northern assays with mouse RNAs demonstrated strong expression of a 1.5-kb tendin transcript in the diaphragm, skeletal muscle, and the eye and low levels of expression in all other tissues investigated. In 17.5-day-old mouse embryos, in situ hybridization revealed high levels of tendin transcript in tendons and ligaments. Additional signals were detected in brain and spinal cord, liver, lung, bowels, thymus, and eye. Cartilage, where CHM1 is found, revealed low levels of tendin m-RNA. In adult mice, tendin is expressed in neurons of all brain regions and the spinal cord. The tendin gene is localized in the human Xq22 region, to which several human diseases have been mapped.


Assuntos
Regulação da Expressão Gênica no Desenvolvimento , Substâncias de Crescimento/genética , Peptídeos e Proteínas de Sinalização Intercelular , Ligamentos/fisiologia , Proteínas de Membrana/genética , Tendões/fisiologia , Animais , Sequência de Bases , DNA Complementar , Humanos , Hibridização In Situ , Ligamentos/química , Ligamentos/embriologia , Camundongos , Dados de Sequência Molecular , RNA Mensageiro/análise , Homologia de Sequência de Aminoácidos , Tendões/química , Tendões/embriologia
19.
Oncogene ; 20(1): 48-57, 2001 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-11244503

RESUMO

Alveolar soft part sarcoma (ASPS) is an unusual tumor with highly characteristic histopathology and ultrastructure, controversial histogenesis, and enigmatic clinical behavior. Recent cytogenetic studies have identified a recurrent der(17) due to a non-reciprocal t(X;17)(p11.2;q25) in this sarcoma. To define the interval containing the Xp11.2 break, we first performed FISH on ASPS cases using YAC probes for OATL1 (Xp11.23) and OATL2 (Xp11.21), and cosmid probes from the intervening genomic region. This localized the breakpoint to a 160 kb interval. The prime candidate within this previously fully sequenced region was TFE3, a transcription factor gene known to be fused to translocation partners on 1 and X in some papillary renal cell carcinomas. Southern blotting using a TFE3 genomic probe identified non-germline bands in several ASPS cases, consistent with rearrangement and possible fusion of TFE3 with a gene on 17q25. Amplification of the 5' portion of cDNAs containing the 3' portion of TFE3 in two different ASPS cases identified a novel sequence, designated ASPL, fused in-frame to TFE3 exon 4 (type 1 fusion) or exon 3 (type 2 fusion). Reverse transcriptase PCR using a forward primer from ASPL and a TFE3 exon 4 reverse primer detected an ASPL-TFE3 fusion transcript in all ASPS cases (12/12: 9 type 1, 3 type 2), establishing the utility of this assay in the diagnosis of ASPS. Using appropriate primers, the reciprocal fusion transcript, TFE3-ASPL, was detected in only one of 12 cases, consistent with the non-reciprocal nature of the translocation in most cases, and supporting ASPL-TFE3 as its oncogenically significant fusion product. ASPL maps to chromosome 17, is ubiquitously expressed, and matches numerous ESTs (Unigene cluster Hs.84128) but no named genes. The ASPL cDNA open reading frame encodes a predicted protein of 476 amino acids that contains within its carboxy-terminal portion of a UBX-like domain that shows significant similarity to predicted proteins of unknown function in several model organisms. The ASPL-TFE3 fusion replaces the N-terminal portion of TFE3 by the fused ASPL sequences, while retaining the TFE3 DNA-binding domain, implicating transcriptional deregulation in the pathogenesis of this tumor, consistent with the biology of several other translocation-associated sarcomas. Oncogene (2001) 20, 48 - 57.


Assuntos
Cromossomos Humanos Par 17/genética , Proteínas de Ligação a DNA/genética , Proteínas de Neoplasias/genética , Proteínas de Fusão Oncogênica/genética , Sarcoma Alveolar de Partes Moles/genética , Fatores de Transcrição/genética , Translocação Genética , Cromossomo X/genética , Adolescente , Adulto , Sequência de Aminoácidos , Axila , Sequência de Bases , Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos , Southern Blotting , Criança , Quebra Cromossômica , Mapeamento Cromossômico , DNA Complementar/isolamento & purificação , Extremidades , Feminino , Perfilação da Expressão Gênica , Humanos , Hibridização in Situ Fluorescente , Peptídeos e Proteínas de Sinalização Intracelular , Cariotipagem , Masculino , Dados de Sequência Molecular , Proteínas de Neoplasias/biossíntese , Proteínas de Neoplasias/isolamento & purificação , Proteínas de Fusão Oncogênica/biossíntese , Proteínas de Fusão Oncogênica/isolamento & purificação , Especificidade de Órgãos/genética , RNA Mensageiro/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de Proteína , Células Tumorais Cultivadas
20.
Int J Mol Med ; 7(2): 155-61, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11172618

RESUMO

A number of distinct, partly non-overlapping genetic loci have been reported for the complete type of X-linked congenital stationary night blindness (CSNB1), suggesting genetic heterogeneity. In order to refine the localization of the CSNB1 gene and to demonstrate genetic homogeneity, linkage analysis was performed in two large CSNB1 families. Clinical features consistent with the diagnosis of CSNB1 were documented in five patients from a German seven-generation kindred by full ophthalmological examination including psychophysical and electroretinographical testing. Haplotype analysis in 30 members of the large German family was performed with 38 polymorphic markers predominantly covering the critical region. Linkage analyses defined a locus for CSNB1 with flanking markers DXS8042 and DXS228, refining the interval to 2.5 cM in Xp11.4. In addition, two-point linkage analysis was carried out using the MLINK computer program. In agreement with meiotic breakpoints, lod scores of 3.0 and greater were obtained for markers located to the proximal site of the former 5 cM CSNB consensus interval. A large Dutch CSNB1 family was re-evaluated with markers from the Xp11.4 region, and supports the CSNB1 minimal interval found in the German family. Together with previous results from three unrelated families from Sweden, Sardinia and Great Britain, our results provide evidence of genetic homogeneity in the disorder. Subsequent mutation analyses in CSNB1 patients revealed no pathogenic sequence alterations in DFFRX and CASK genes, but retain candidates for other diseases mapping to that region.


Assuntos
Ligação Genética , Cegueira Noturna/genética , Cromossomo X/genética , Proteínas Quinases Dependentes de Cálcio-Calmodulina/genética , Mapeamento Cromossômico , Endopeptidases/genética , Europa (Continente) , Feminino , Haplótipos , Humanos , Escore Lod , Masculino , Cegueira Noturna/congênito , Linhagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...